跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aprezal - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Aprezal
Approved
STANDARD
Aprezal
Kwality Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fcfa9cba493073eb
Company
Kwality Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
fcfa9cba493073eb
Drug Approval Philippines Name
Aprezal
Product Name
Aprezal
Registration Number
DR-XY40652
Brand Name
Aprezal
Generic Name
Hydralazine Hydrochloride
Dosage Form
Solution For Injection (I.M./I.V.)
Dosage Strength
20 mg/mL
Manufacturer
Kwality Pharmaceuticals Pvt. Ltd.
Importer
Phil Pharmawealth, Inc.
Distributor
Phil Pharmawealth, Inc.
Issuance Date
30 January 2022
Expiry Date
16 February 2027
Pharmacologic Category
Direct Vasodilators
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fcfa9cba493073eb
Type
Standard
Back to Philippines FDA Approvals